What does MEDIBRAIN do?

MEDIBRAIN is a specialist medical practice in Sint-Genesius-Rode. Private Limited, started on 13 August 2008, 1 establishment.

What is the address of MEDIBRAIN?

The registered office of MEDIBRAIN is located at Korenbloemenlaan 35, 1640 Sint-Genesius-Rode.

Is MEDIBRAIN still active?

Yes. According to the CBE (2 November 2026) MEDIBRAIN is active, legal situation “Normale toestand”, started on 13 August 2008.

Is MEDIBRAIN registered on Peppol?

Yes, MEDIBRAIN is registered on the Peppol network with ID 0208:0899783282.

What is the enterprise number of MEDIBRAIN?

The enterprise number of MEDIBRAIN is BE0899783282.

When was MEDIBRAIN founded?

MEDIBRAIN was founded on 13 August 2008.

Who are the directors of MEDIBRAIN?

According to the 2025 annual accounts, the directors of MEDIBRAIN are: BORIS LUBICZ.

Is MEDIBRAIN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 August 2008; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDIBRAIN make in 2025?

MEDIBRAIN posted a profit after taxes of € 539,697 in financial year 2025.

What is the revenue of MEDIBRAIN?

As a small company, MEDIBRAIN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 841,835.

MEDIBRAIN (Private Limited) - Sint-Genesius-Rode

Dossier MEDIBRAIN, printed on 2 November 2026 from databakkes.be/en/0899783282/medibrain. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDIBRAIN from Sint-Genesius-Rode, company number BE0899783282, closed financial year 2025 with a result of € 539,697 after tax. For that financial year MEDIBRAIN recorded a gross margin of € 841,835 and equity of € 2 million. Compared with financial year 2024, the result moved from € 494,191 to € 539,697. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 5, 2026.

What it is worth Growing

€ 2 million

▲ 31% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 539,697

▲ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 317,470

▲ 217% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 80,000 paid out

15 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 46,656

▲ 3% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 41,864

▲ 86% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,563

▼ 73% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 102,692

▲ 18% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 378,162 Gross margin 2022: € 378,162 First fiscal year in the series	€ 476,825 Gross margin 2023: € 476,825 ▲ 26% vs 2022 (€ 378,162) Favourable step	€ 757,717 Gross margin 2024: € 757,717 ▲ 59% vs 2023 (€ 476,825) Favourable step	€ 841,835 Gross margin 2025: € 841,835 ▲ 11% vs 2024 (€ 757,717) Favourable step	▲ 11%
Profit after taxes	€ 246,903 Profit after taxes 2022: € 246,903 First fiscal year in the series	€ 306,722 Profit after taxes 2023: € 306,722 ▲ 24% vs 2022 (€ 246,903) Favourable step	€ 494,191 Profit after taxes 2024: € 494,191 ▲ 61% vs 2023 (€ 306,722) Favourable step	€ 539,697 Profit after taxes 2025: € 539,697 ▲ 9% vs 2024 (€ 494,191) Favourable step	▲ 9%
Equity	€ 939,893 Equity 2022: € 939,893 First fiscal year in the series	€ 1,071,480 Equity 2023: € 1,071,480 ▲ 14% vs 2022 (€ 939,893) Favourable step	€ 1,492,170 Equity 2024: € 1,492,170 ▲ 39% vs 2023 (€ 1,071,480) Favourable step	€ 1,951,867 Equity 2025: € 1,951,867 ▲ 31% vs 2024 (€ 1,492,170) Favourable step	▲ 31%
Total debts	€ 115,292 Total debts 2022: € 115,292 First fiscal year in the series	€ 67,908 Total debts 2023: € 67,908 ▼ 41% vs 2022 (€ 115,292) Favourable step	€ 105,432 Total debts 2024: € 105,432 ▲ 55% vs 2023 (€ 67,908) Unfavourable step	€ 108,863 Total debts 2025: € 108,863 ▲ 3% vs 2024 (€ 105,432) Unfavourable step	▲ 3%
Cash	€ 168,858 Cash 2022: € 168,858 First fiscal year in the series	€ 116,035 Cash 2023: € 116,035 ▼ 31% vs 2022 (€ 168,858) Unfavourable step	€ 100,113 Cash 2024: € 100,113 ▼ 14% vs 2023 (€ 116,035) Unfavourable step	€ 317,470 Cash 2025: € 317,470 ▲ 217% vs 2024 (€ 100,113) Favourable step	▲ 217%
Retained profit	€ 939,893 Retained profit 2022: € 939,893 First fiscal year in the series	€ 1,071,480 Retained profit 2023: € 1,071,480 ▲ 14% vs 2022 (€ 939,893) Favourable step	€ 1,492,170 Retained profit 2024: € 1,492,170 ▲ 39% vs 2023 (€ 1,071,480) Favourable step	€ 1,951,867 Retained profit 2025: € 1,951,867 ▲ 31% vs 2024 (€ 1,492,170) Favourable step	▲ 31%
Dividend	€ 297,174 Dividend 2022: € 297,174 First fiscal year in the series	€ 175,135 Dividend 2023: € 175,135 ▼ 41% vs 2022 (€ 297,174) Unchanged	€ 73,500 Dividend 2024: € 73,500 ▼ 58% vs 2023 (€ 175,135) Unchanged	€ 80,000 Dividend 2025: € 80,000 ▲ 9% vs 2024 (€ 73,500) Unchanged	▲ 9%
Bank debt	€ 115 Bank debt 2022: € 115 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 115) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,055,184 Balance sheet total 2022: € 1,055,184 First fiscal year in the series	€ 1,139,388 Balance sheet total 2023: € 1,139,388 ▲ 8% vs 2022 (€ 1,055,184) Unchanged	€ 1,597,602 Balance sheet total 2024: € 1,597,602 ▲ 40% vs 2023 (€ 1,139,388) Unchanged	€ 2,060,731 Balance sheet total 2025: € 2,060,731 ▲ 29% vs 2024 (€ 1,597,602) Unchanged	▲ 29%

Key figures of MEDIBRAIN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to MEDIBRAIN?

What happened at MEDIBRAIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 5, 2026 New annual accounts for financial year 2025: profit of € 539,697 (▲ 9% vs 2024). filed late Source: NBB ↗
Aug 13, 2008 Start of the company according to the CBE. KBO
Aug 12, 2008 New establishment in Sint-Genesius-Rode. KBO

In short

From € 246,903 profit in 2022 to € 539,697 profit in 2025.

Paid € 764,653 in corporate taxes since 2022.

Best year ever: 2025, with € 539,697 profit.

Paid out € 625,809 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

BORIS LUBICZ

MEDIBRAIN

Behind MEDIBRAIN is BORIS LUBICZ.

Directors

According to the 2025 annual accounts

BORIS LUBICZ

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Korenbloemenlaan 35

1640 Sint-Genesius-Rode

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ABNB Records

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0899.783.282

VAT number

BE 0899.783.282

Registered office

Korenbloemenlaan 35, 1640 Sint-Genesius-Rode

Names & denominations

MEDIBRAIN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

13 August 2008

Peppol

Active · Active since 23 Apr 2025

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten op het gebied van psychologie

Activiteiten van medische beeldvorming en medische laboratoria

Overige vormen van onderwijs

Activiteiten op het vlak van geestelijke gezondheidszorg, m.u.v. psychiatrische ziekenhuizen en verzorgingstehuizen

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDIBRAIN

Financials

What happened to MEDIBRAIN?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions